er-086526 and Colorectal-Neoplasms

er-086526 has been researched along with Colorectal-Neoplasms* in 2 studies

Other Studies

2 other study(ies) available for er-086526 and Colorectal-Neoplasms

ArticleYear
Inhibition of insulin-like growth factor-1 receptor enhances eribulin-induced DNA damage in colorectal cancer.
    Cancer science, 2022, Volume: 113, Issue:12

    Topics: Animals; Cell Line, Tumor; Colorectal Neoplasms; DNA Damage; Humans; Insulin-Like Growth Factor I; Protein Kinase Inhibitors; Receptor, IGF Type 1

2022
Eribulin in BRAF V600E-mutant metastatic colorectal cancer: case series and potential rationale.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2018, 05-01, Volume: 29, Issue:5

    Topics: Aged; ATP Binding Cassette Transporter, Subfamily B; CA-19-9 Antigen; Colorectal Neoplasms; Disease Progression; Fatal Outcome; Female; Furans; Humans; Ketones; Male; Middle Aged; Mitosis; Mutation; Proto-Oncogene Proteins B-raf; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden

2018